Skip to Content

Lung Cancer Therapy Annual 7

7th Edition

Edited by Rolf A. Stahel

Published August 13th 2012 by CRC Press – 176 pages

Purchasing Options:

Description

Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects.

It offers an update of the impact that this information will have on the day-to-day management of the lung cancer patient.

New to the Seventh Edition:

  • An update of the impact of recent developments will have on day-to-day management of lung cancer patients
  • Four new chapters on the treatment of non-small cell lung cancer (NSCLC)
  • A new chapter on thymoma

Additional topics include:

  • Oncogenic driver mutations
  • First line therapy of advanced non-small cell lung cancer without activating EGFR mutation
  • Second line therapy of non-small cell lung cancer
  • Adjunct and neoadjunct therapy of non-small cell lung cancer
  • Advances in surgery of lung cancer; advances in radiotherapy of lung cancer
  • Mesothelioma
  • Thymic tumors

Reviews

"This is an excellent resource for beginners as well as advanced specialists in the field. The references are current to the year 2008 and the individual chapters are brief and complete and will give readers a solid foundation in the treatment of lung cancer to build upon." - K. P. Ravikrishnan, FRCP (C), FACP FCCP(William Beaumont Hospitals)

Contents

1. Epidemiology

2. Prevention, early detection, and screening

3. Staging

4. Histopathology and molecular pathology

5. Oncogenic driver mutations

6. First line therapy of advanced non-small cell lung cancer without activating EGFR mutation

7. First line therapy of advanced non-small cell lung cancer with activating EGFR mutation

8. Second line therapy of non-small cell lung cancer

9. Adjuvant and neoadjuvant therapy of non-small cell lung cancer

10. Advances in surgery of lung cancer

11. Advances in radiotherapy of lung cancer

12. Small cell lung cancer

13. Mesothelioma

14. Thymoma

Author Bio

Rolf A. Stahel, M.D. is head of the Center for Lung and Thoracic Oncology and Senior Staff Physician at the Clinic of Oncology, University Hospital of Zürich as well as Titular Professor of Medicine at the University of Zürich, Switzerland. He is certified in Internal Medicine and Medical Oncology by both the American and Swiss Board. His major interest is thoracic oncology, including multidisciplinary treatment approaches, translational research, and targeted therapy.

Name: Lung Cancer Therapy Annual 7: 7th Edition (Hardback)CRC Press 
Description: Edited by Rolf A. Stahel. Oncology research and practice in lung cancer continues to develop rapidly. This latest edition of Lung Cancer Therapy Annual briefs the oncology community with a review of the recent literature, emphasizing the therapeutic aspects. It offers an update...
Categories: Oncology, Pulmonary Medicine